Infertility Devices Market Analysis

The global infertility devices market is estimated to be valued at US$ 10,129.9 million in 2023 and is expected to exhibit a CAGR of 8.7% during the forecast period (2023-2030).

Analysts’ Views on Global Infertility Devices Market: 

Increasing inorganic strategies such as acquisition by key market players is expected to drive the infertility devices market growth over the forecast period. For instance, in July 2021, Vitrolife AB, an Invitro Fertilization (IVF) company, entered into a definitive agreement to acquire 100% of the shares in Igenomix S.L.,  a medical testing laboratory specializing in reproductive genetic services. The acquisition will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services.

Figure 1. Global Infertility Devices Market Share (%), by Product Type, 2023

Global Infertility Devices Market – Driver

Increasing inorganic strategies by key players  

Increasing inorganic strategies such as acquisition by the key market players is expected to drive the infertility devices market growth over the forecast period. For instance, in December 2021, Cooper Companies Inc., amedical device company announced it has purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, for fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue).

Figure 2. Global Infertility Devices Market Value (US$ Million), by Region, 2023          

Global Infertility Devices Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global infertility devices market over the forecast period. For instance, in February 2022, INVO Bioscience, Inc., a commercial-stage fertility company, announced plans to open its next INVO Center in Tampa, Florida, U.S.

Global Infertility Devices Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

The COVID-19 pandemic affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

The COVID-19 afffected the market negatively as most of the hospitals and beds were acquired by the COVID-19 pateints.

Infertility Devices Market Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2023:	US$ 10,129.9 Mn
Historical Data for:	2017 to 2021	Forecast Period:	2023 to 2030
Forecast Period 2023 to 2030 CAGR:	8.7%	2030 Value Projection:	US$ 18,128.8 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Equipment (Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Accessories) By Procedure: Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery, Others    By Gender: Male, Female By End User: Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Others
Companies covered:	Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD, Merck,
Growth Drivers:	Increasing prevalence of infertility
Restraints & Challenges:	High cost of the procedure

Global Infertility Devices Market Segmentation:

The global infertility devices market report is segmented into Product Type, Procedure, Gender, End User and Region

Based on Products, the market is segmented into equipment and accessories, in which equipment segment is sub segmented into imaging systems, sperm analyzer systems, ovum aspiration pumps, micromanipulators systems, incubators, gas analyzers, laser systems and cryosystems. Out of which, the sperm analyzer segment is expected to hold a dominant position in the global infertility devices market over the forecast period.

Based on Procedures, the infertility devices market is segmented into assisted reproductive technology, artificial insemination, fertility surgery, and others. Out of which the assisted reproductive technology segment is expexted to hold a dominant postion in the global infertility devices market over the forecast.

Based on Gender, the infertility devices market segmented into males and females.

Based on End User, the infertility devices market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and others. Out of which, the fertility centers segment is expected to hold a dominant position in the market over the forecast period.

Global Infertility Devices Market Cross Sectional Analysis:

Among regions, the Asia Pacific region expected to hold the second dominat position in the infertility devices market followed by North America, over the forecast period. For instance, in November 2021, Vitrolife AB, announced that it will be expanding its distribution of genomic testing kits to the Asia Pacific region (excluding China).

Global Infertility Devices Market: Key Developments

For instance, in May 2021, a data was published by the Medical Device Network, magazine for the medical device industry, according to that Medical Device Network talks to Alife Health CEO Paxton Maeder-York about the growing role of AI during IVF procedures. Alife is artificial intelligence (AI) company that has yet to release any products but aims to create a software platform to support clinical decision-making during the IVF process.  

Global Infertility Devices Market: Key Trends

Increasing inorganic strategies by the key market players to drive the infertility devices market growth over the forecast period

For instance, in February 2022, Cooper Companies Inc., a medical device company, announced that had signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. 

Global Infertility Devices Market: Restraint                      

High cost of the procedure

The global infertility devices market can be hindered by high cost of the procedure and lack of awareness among people. For instance, in April 2021, a data was published by National Center for Biotechnology Information (NCBI), according to which the public policy about the economic burden of infertility estimated at  US$ 77.1 Mn, for 10,000 women aged between 18 and 50.

Global Infertility Devices Market - Key Players

Major players operating in the global infertility devices market include Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD

Definition: Infertility is a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Infertility affects millions of people – and has an impact on their families and communities. Estimates suggest that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.